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PPathological Findings at Bifurcation Lesions
The Impact of Flow Distribution on Atherosclerosis
and Arterial Healing After Stent Implantation
Gaku Nakazawa, MD,* Saami K. Yazdani, PHD,* Aloke V. Finn, MD,† Marc Vorpahl, MD,*
Frank D. Kolodgie, PHD,* Renu Virmani, MD*
Gaithersburg, Maryland; and Atlanta, Georgia
Objectives Using human pathologic specimens from the CVPath registry, we aimed to investigate the location of the athero-
sclerotic plaque at bifurcation in native coronary atherosclerotic lesions and to determine the responses at bifur-
cation after implantation of bare-metal stents (BMS) and drug-eluting stents (DES).
Background Greater atherosclerotic plaque burden has been reported to occur at low-shear regions of bifurcation.
Methods Twenty-six randomly selected human atherosclerotic nonstented coronary bifurcation lesions were examined
longitudinally for plaque distribution in patients dying of severe coronary artery disease. Forty stented bifurcation
lesions (21 BMS and 19 DES) were reviewed and analyzed by morphometry.
Results In nonstented coronary bifurcations, the lateral wall showed significantly greater intima as well as necrotic core
thickness than the flow divider. In the stented lesion, the frequency of late stent thrombosis was greater in the
DES group (75%) than in the BMS group (36%), whereas restenosis was more frequent in the BMS group (33%)
than in the DES group (5%). Neointimal formation was significantly less at the flow divider compared with the
lateral wall in the DES group (0.07 mm [interquartile range (IQR) 0.03 to 0.15 mm] vs. 0.17 mm [IQR 0.09 to
0.23 mm]; p  0.001), whereas this difference was not significant in the BMS group. Similarly, uncovered struts
and fibrin deposition was significantly greater at the flow divider compared with the lateral wall in the DES group
(uncovered: 40% [IQR 16% to 76%] vs. 0% [IQR 0% to 15%]; p  0.001; fibrin: 60% [IQR 21% to 67%] vs. 17%
[IQR 0% to 55%]; p  0.01), but not in the BMS group.
Conclusions Plaque formation in native coronary bifurcations and neointimal growth after DES implantation was significantly
less at the flow divider versus the lateral wall. A higher prevalence of late stent thrombosis in DES compared
with BMS was associated with greater uncovered struts at flow divider sites, which is likely due to flow
disturbances. (J Am Coll Cardiol 2010;55:1679–87) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.01.021a
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dtherosclerotic lesions tend to form at specific regions of
he coronary vasculature where flow is disturbed, particularly
n areas of low shear (1–3). Because dramatic hemodynamic
lternations occur at branch points within the arterial tree,
oronary bifurcations are extraordinarily susceptible to
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009, accepted January 20, 2010.therosclerosis. Areas of low-shear stress are thought to
ccelerate atherosclerosis through modulation of gene ex-
ression, including the promotion of endothelial cell dys-
unction, which causes increased uptake of lipoproteins,
pregulation of leukocyte adhesion molecules, and leukocyte
ndothelial transmigration, all of which contribute to the
evelopment and progression of atherosclerosis (4).
It is estimated that coronary bifurcation lesions are
nvolved in up to 10% of all percutaneous coronary inter-
entions (PCIs) (5). Early results using bare-metal stents
BMS) to treat bifurcation lesions resulted in a high
ngiographic acute success rate, but were limited by a higher
ate of restenosis (6,7). Although the use of drug-eluting
tents (DES) has reduced restenosis rates in bifurcation
esions, long-term outcomes are tempered by an increased
isk for thrombosis (8), which raises the possibility that
elayed healing seen after DES implantation may be exac-
rbated at bifurcation sites, perhaps secondary to stent-
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combination with locally eluted
drugs.
The aim of the present study
was to determine the role of
shear stress on plaque formation
at bifurcation sites and the influ-
ence of flow patterns in stented
oronary arteries. We assessed the anatomic distribution
f atherosclerotic plaque in human coronaries using the
VPath Sudden Cardiac Death Registry and compared
he pathologic arterial response with bifurcation stenting
ith DES and BMS cases from the CVPath stent
egistry.
ethods
atient population. From the CVPath Sudden Cardiac
eath Registry, nonstented bifurcation lesions that had
een cut longitudinally were examined in patients dying of
udden cardiac death with severe coronary artery disease
more than 75% stenosis in 1 or more epicardial coronary
rteries). For stented lesions, the CVPath Stent Registry
as reviewed to select bifurcation lesions that had been
reated with DES and BMS (collected from 1999 to 2008).
Abbreviations
and Acronyms
BMS  bare-metal stent(s)
DES  drug-eluting stent(s)
PCI  percutaneous
coronary intervention
Main Vessel 
proximal
Side BranchMain Vessel distal
High shear　　　　Low 
shear
A
B
C
D
E F
G
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Figure 1 Morphometric Analysis
(A) Illustration showing how, for nonstented atherosclerotic lesions, sections were
vessel on the lateral wall; C, proximal main vessel on the branch side; D, distal si
side branch on the flow divider side; G, carinal area. (B) Illustration of the method
drug-eluting stents with regions of interest (flow divider and lateral wall).or the case to be included as a bifurcation lesion in the stent
tudy, the main branch stent had to be located in a major
picardial coronary artery and the stented segment had to
nclude a side branch diameter of 2 mm or more in diameter.
istologic preparation. All specimens had been perfusion
xed at 100 mm Hg with 10% buffered formalin. Hearts
ere X-rayed and then the epicardial coronary arteries were
issected off the heart and reradiographed. Nonstented
rteries were submitted for paraffin embedding and were cut
ongitudinally. Stented arteries were submitted for plastic
mbedding and were cross sectioned serially at 2- to 3-mm
ntervals. Also, proximal and distal nonstented coronary
rteries were dehydrated and were embedded in paraffin for
urther examination. All sections were stained with hema-
oxylin and eosin and Movat pentachrome as described
reviously (9,10).
athologic assessment and morphometric analysis. In
onstented coronary bifurcation lesions, the intimal thick-
ess was measured and compared among the different loca-
ions, that is, the lateral wall of the main branch (proximal and
istal to bifurcation), the flow divider region of the main and
ide branch, and the lateral wall of the side branch (Fig. 1A).
imilarly, necrotic core thickness also was measured.
1 or 2 sections
Lateral wall
Flow divider
ssed based on the longitudinal location: A, proximal main vessel; B, distal main
nch on the lateral wall; E, distal main vessel on the flow divider side; F, distal
ctioning of the main and side branch cross sections in the bare-metal stents andB
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April 20, 2010:1679–87 Pathology of Bifurcation Lesion and StentingIn stented lesions, the presence of acute thrombus was
efined as a platelet-rich thrombus that occupied more than
0% of the cross-sectional area of the lumen, and restenosis
as defined as a more than 75% cross-sectional area
arrowing by neointimal formation as reported previously
10). Stent-related death was defined as either related to
tent thrombosis or restenosis or to procedure-related death
i.e., coronary perforation, dissection). Nonstent-related
ardiac death was defined as a patent stent without evidence
f thrombus or restenosis in association with 1 or more
onstented major coronary artery stenosis (cross-sectional
rea narrowing of more than 75%) or presence of congestive
eart failure, valvular heart disease, or both.
To assess the impact of flow disturbance on arterial
ealing in stented lesions, the differences between flow
ivider and lateral wall sites were compared (Fig. 1B).
eointimal thickness above the stent struts was defined as
he mean thickness between luminal surface of the strut and
essel lumen, which was measured using calibrated software
IPLab, BD Bioscience Bioimaging, Rockville, Maryland).
he number of stent struts surrounded by fibrin deposition
as recorded, and the percent of struts with fibrin was
alculated by the following formula: (number of struts with
brin/total struts number in the region)  100. An uncov-
red strut was defined as a stent strut without neointimal
overage, surface endothelium, or both, and the ratio of
ncovered to total stent struts per section was calculated as
escribed previously (11). All parameters were recorded
eparately in flow divider and lateral wall sites, respectively.
n vitro flow model. To determine the effects of a stent on
ow disturbances, a transparent elastomeric silicone (Syl-
ard 184, Dow Corning Corporation, Midland, Missouri)
ith an inner diameter of 3.2 mm, wall thickness of 0.5 mm,
nd an angle of 40° was created (12). The bifurcation model
as positioned within a closed-flow loop system consisting
f a computer-controlled gear pump, flow reservoir, and
ow constrictors. An ultrasonic flow meter (Transonic
ystems, Inc., Ithaca, New York) and pressure transducer
atheter system (Millar Instruments, Inc., Houston, Texas)
ere used to monitor the pulsatile flow conditions. Flow
onstrictors downstream of the bifurcation were adjusted to
reate a 65:35 split ratio of flow through the daughter tubes.
o visualize the flow, the circulating media was seeded with
eutrally buoyant glass sphere particles (18 m; Potters
ndustries, Inc., Valley Forge, Pennsylvania), excited with a
25-mW green laser (Dragon Lasers, ChangChun, China),
nd captured using a fast CMOS digital camera (600
rames/s; Vision Research, Wayne, New Jersey). A balloon-
xpandable BMS (3.0  12 mm; Multi-Link Vision,
bbott Vascular, Santa Clara, California) was inflated to a
nal diameter of 3.5 mm within the bifurcation model,
ollowed by side branch dilatation with final kissing balloon
nflation for 20 seconds. The flow conditions of our system
imicked that of native human arterial circulation with a
ean Reynolds number of 436 (66 ml/min) and a Wom-rsely parameter of 4.00 (60 beats/min), with pressure vanging from 60 to 120 mm Hg, which corresponds to
hysiological conditions. The Reynolds and Womersely
umbers are nondimensional parameters that govern flow
haracteristics and are used to mimic similar hemodynamic
nvironments between native arteries and modeling systems.
tatistical analysis. Normally distributed continuous vari-
bles are expressed as mean  SD. Discrete variables and
ontinuous variables with non-normal distribution were
xpressed as median and interquartile range. Comparisons
f plaque and necrotic core thickness between each location
ere performed using the paired t test. Comparison be-
ween the DES and BMS groups were tested by the Student
test for normally distributed continuous variables and the
isher exact test for categorical variables. The Wilcoxon
ank-sum test was used for comparison of non-normally
istributed parameters and discrete variables. The Wilcoxon
igned-rank test was used for comparisons of neointimal
hickness, percent of struts with fibrin deposition, and
ercent of uncovered struts between flow divider versus
ateral wall site within the same lesion. No corrections were
ade for correlated observations within the same individu-
ls. The normality of distribution was tested with the
ilk-Shapiro test. A value of p  0.05 was considered
tatistically significant.
esults
nalysis for nonstented bifurcation lesions (atherosclerosis).
wenty-six bifurcation lesions in 18 patients (male; 88%)
ying of severe coronary artery disease were examined (left
ain/left anterior descending coronary artery/left circumflex
5; left anterior descending coronary artery/left diagonal
4; left circumflex/left obtuse marginal  5; left circumflex/
osterior descending  1; right coronary artery/posterior
escending  1). A mean age of the population was 60 
0 years, with a mean body mass index of 29  7 kg/m2.
hirteen patients (72%) had known coronary risk factors
uch as hypertension (n  6), diabetes (n  4), smoking
n  3), pre-existing coronary artery disease (n  4), or
combination thereof. All coronary bifurcations had
therosclerotic plaques. Plaque types were thin-cap fibro-
theroma (n  2), fibroatheroma with or without calci-
cation (n  11, with or without  5 of 6), and fibrocalcific
laques (n  13).
The mean longitudinal length of the proximal segment in
he main vessel to the branch point was 7.2  3.0 mm, and
he distance from branch point to the distal end of the
tented segment was 6.7  2.8 mm. Plaque thickness was
he greatest on the lateral wall in the distal main vessel (1.3 0.7
m), followed by the lateral wall in the proximal main
essel (1.1  0.7 mm). All lateral walls showed signifi-
antly greater intimal thickness as compared with those
n the flow divider (Fig. 2). Similarly, necrotic core
hickness also was significantly greater in the lateral wall
ersus the flow divider, where the necrotic core was
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Pathology of Bifurcation Lesion and Stenting April 20, 2010:1679–87inimal or absent (Fig. 2). Figure 3 illustrates typical
rowth of necrotic core at bifurcation sites.
tented bifurcation lesions. Forty stented bifurcation le-
ions (DES, n  19; BMS, n  21) from 40 patients with
n age of 61 16 years in the DES group and 58 17 years
n the BMS group (p  0.61) were evaluated. The preva-
ence of males (DES, 79% vs. BMS, 62%; p  0.49) and a
ean implant duration (median [interquartile range IQR]:
ES, 330 days [188 to 680 days] vs. BMS, 150 days [IQR
4 to 540 days]; p 0.14) was similar between the 2 groups.
rocedural parameters such as location of bifurcation le-
ions, techniques of stenting, and number of implanted
tents were comparable (Table 1). Restenosis in the main
essel was significantly more frequent in BMS group as
ompared with the DES group (33% vs. 5%; p  0.046)
Table 1). The incidence of late stent thrombosis (more
han 30 days) in the main vessel was borderline significantly
reater in the DES versus the BMS group (75% vs. 36%;
 0.06) (Table 1, Fig. 4), whereas acute or subacute stent
hrombosis (fewer than 30 days) was similar between the
ES and BMS groups (Table 1). The stent duration of late
tent thrombosis (more than 30 days) was significantly
onger in the DES group as compared with the BMS group
270 days [IQR 195 to 585 days] vs. 60 days [IQR 35 to 105
Figure 2 Distribution of Coronary Plaque in Bifurcation Lesion
Bar graphs showing the bifurcation lesions as divided into 7 regions: (A) thick-
ness of the plaque (mm) in each region, (B) thickness of the necrotic core
(mm). Low-shear areas had a higher prevalence of coronary plaque as well as
necrotic core. Note that carinal region was rarely involved (G). p  0.05 versus
*A, versus †B, versus ‡C and D.ays]; p  0.003).
d
TIn patients who died within 30 days of stent implanta-
ion, the cause of death was similar between the DES and
MS groups (Table 1). Both stent groups had 4 stent-
elated death (DES group, 3 thrombosis and 1 coronary
erforation; BMS group, 3 thrombosis and 1 coronary
erforation), 2 nonstent-related cardiac deaths in each
roup (DES group, 1 diffuse coronary artery disease and 1
ardiogenic shock after acute myocardial infarction; BMS
roup, 1 diffuse coronary artery disease and 1 cardiogenic
hock after acute myocardial infarction), and 1 noncardiac
eath in each group (DES group, 1 sepsis; BMS group, 1
epsis). However, among the patients who died more than
0 days after stent implantation, the incidence of stent-
elated death was greater in patients with DES (9 of 12;
5%) as compared with those with BMS (5 of 14; 36%), but
he difference remained of borderline significance because of
limited sample size. Nonstent-related death was docu-
ented in 3 patients (25%) with a DES (2 diffuse coronary
rtery disease and 1 severe aortic stenosis) and in 4 patients
29%) with a BMS (3 diffuse coronary artery disease and 1
atient, Lesion, and Proceduralharacteristics and Pathologic FindingsTable 1 Patie t, Lesi n, and ProceduralCharacteristics and Pathologic Findings
DES
(n  19)
BMS
(n  21) p Value
Age (yrs) 61 16 58 17 0.61
Males 15 (79) 13 (62) 0.49
Mean duration (days)* 330 (188–680) 150 (54–540) 0.14
More than 30 days 12 (63) 14 (67)  0.99
Location
LM/LAD/LCX 4 1 0.44
LAD/LD 10 12
LCX/OM 4 7
RCA/PDA 1 1
Technique
1 stent 10 9 0.38
2 stents: T/V/crush 5/2/2 9/3/0
No. of stents* 2 (1–2) 2 (1–2) 0.55
Restenosis
MV 1 (5) 7 (33) 0.046
SB 3 (16) 6 (29) 0.46
Thrombosis
30 days
MV 3/7 (43) 3/7 (43) 0.99
SB 3/7 (43) 4/7 (57) 0.59
30 days
MV 9/12 (75) 5/14 (36) 0.06
SB 5/12 (42) 2/14 (14) 0.19
Timing of thrombus*
(30 days)
270 (195–585) 60 (35–105) 0.003
Cause of death
SRD/NSRCD/NCD
30 days
4/2/1 4/2/1 0.99
30 days 9/3/0 5/4/5 0.04
alues are mean  SD, n (%), or n. *Expressed as median (interquartile range).
BMS bare-metal stent(s); DES drug-eluting stent(s); LAD left anterior descending coronary
rtery; LCX  left circumflex; LD  left diagonal; LM  left main; MV  main vessel; NSRCD 
onstent-related cardiac death; NCD noncardiac death; OM obtuse marginal; PDA posterior
escending artery; RCA  right coronary artery; SB  side branch; SRD  stent-related death;
/V  T-stenting/V-stenting.
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April 20, 2010:1679–87 Pathology of Bifurcation Lesion and Stentingcute myocardial infarction in nontreated vessel). Noncar-
iac death was observed in 5 patients (36%) in the BMS
roup (2 trauma, 1 cancer, 1 complication of surgery, and 1
erebrovascular disease) and none in the DES group.
athologic assessment and morphometric analysis (stent
mplant duration of more than 30 days). Neointimal
hickness was significantly less at the flow divider site as
ompared with the lateral wall in the DES group (median
interquartile range]: 0.07 mm [IQR 0.03 to 0.15 mm] vs.
.17 mm [IQR 0.09 to 0.23 mm]; p  0.001), whereas this
ifference did not reach statistical significance for BMS
ases (0.26 mm [IQR 0.16 to 0.73 mm] vs. 0.44 mm [IQR
.17 to 0.67 mm]; p  0.25). Similarly, the percentage of
ncovered struts was significantly greater at flow divider
ites as compared with the lateral wall in the DES group
40% [IQR 16% to 76%] vs. 0% [IQR 0% to 15%; p 
.001]), whereas there was no significant difference in the
Figure 3 Representative Histologic Images of Coronary Plaque
(A) Longitudinal section of trifurcation: left main (LM)/proximal left anterior desce
(B) Atherosclerotic plaques were observed in the lateral wall, whereas the flow div
LCx/left obtuse marginal bifurcation. Note the severe luminal narrowing proximal a
development, including necrotic core formation, whereas flow divider regions (the c
orphometric Comparison Between Flow Divider Versus Lateral WaTable 2 Morphometric Comparison Between Flow Divider Versu
DES
(12 Lesions, 17 Stents)
p ValuFlow Divider Lateral
Neointimal thickness (mm) 0.07 (0.03–0.15) 0.17 (0.09–0.23) 0.001
Fibrin deposition (% struts) 60 (21–67) 17 (0–55) 0.01
Uncovered struts (% struts) 40 (16–76) 0 (0–15) 0.001alues are expressed as median (interquartile range).MS group (0% [IQR 0% to 21%] vs. 0% [IQR 0% to 0%]:
 0.09). Fibrin deposition also was seen frequently in flow
ivider sites as compared with the lateral wall (60% [IQR
1% to 67%] vs. 17% [IQR 0% to 55%]; p  0.01) (Table
), which was observed only in the DES group. Most of the
hrombi originated at the flow divider sites, where uncov-
red struts were observed frequently.
The DES group showed significantly greater fibrin dep-
sition and uncovered struts and less neointimal thickness as
ompared with the BMS group at flow divider sites, whereas
here was no statistical significance in fibrin deposition and
ncovered struts between the DES and BMS groups at the
ateral wall.
tent-induced flow disturbances. The character of flow in
stented region is governed by the flow waveform, pulsa-
ility, and compliance mismatch. Therefore, to better exam-
ne the temporal and spatial evolution of the flow in our
furcation Lesion
oronary artery (PLAD)/ramus intermedicus (RI)/proximal left circumflex (PLCx).
gions were spared. (C) Longitudinal section obtained from the region of the
tal to the bifurcation. (D, E) Low-shear regions show atherosclerotic plaque
have minimal intimal thickening.
DES and BMSteral Wall in DES and BMS
BMS
(14 Lesions, 18 Stents)
p Value
p Value for
DES vs. BMS
Flow Divider Lateral Flow Divider Lateral
0.26 (0.16–0.73) 0.44 (0.17–0.67) 0.25 0.0002 0.004
8 (0–33) 3 (0–21) 0.21 0.008 0.19
0 (0–21) 0 (0–0) 0.10 0.004 0.38in Bi
nding c
ider re
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Pathology of Bifurcation Lesion and Stenting April 20, 2010:1679–87ifurcation model and to determine the effects of a stent, 2
hases of the flow were examined. Phase 1 included peak
ystolic of the flow, at which flow separation of the lateral
alls is known to occur. Phase 2 included early diastole, as
ow begins to decelerate and become unstable.
In the nonstented bifurcation model, the flow during the
eak systolic phase produced large boundary layer separation
low-shear stress) at the lateral wall, whereas the flow
emained attached at the flow divider regions (high-shear
tress). During the early diastolic phase, flow decelerated
nd reversed; however, no secondary vortical structures were
bserved within the carinal region. After deployment of
tent, the boundary layer separation of the lateral walls was
till present; however, the region of separation at the side
ranch had increased as compared with the nonstented
odel. Side branch expansion of the stent resulted in a
eduction of the boundary layer separation of the side
ranch (Fig. 5). During the early diastolic phase, as flow
ecelerated, vortical flow structures were observed in the
arinal region (Fig. 5H). All observations were conducted in
bifurcation model of 40° with a flow split ratio of 65:35.
LM
LAD
LCX
XLC
Thr
Thr
Thr
Thr
AB
D
E
G
Figure 4 A Case of Late Drug-Eluting Stent Thrombosis in Bifur
A 55-year-old man with a history of smoking, hypertension, and dyslipidemia receiv
and left circumflex (LCX), with overlapping Taxus stents placed in the LAD. The pat
mildly calcified coronary artery. (A) Both stents were occluded with platelet-rich thr
onstrated adherent thrombus in the region of the uncovered struts at the flow divi
tions of the LCX stent. (D, F, H) The middle to distal portion of the LAD stent sho
LM  left main artery.e acknowledge that varying the angle and flow ratio
urther may lead to more or fewer flow disturbances (13).
oreover, the peak flow of our model was in phase with
eak systolic pressure, which differs from native coronary
lood flow.
iscussion
he main findings of the present study were: 1) atheroscle-
otic plaques developed at bifurcation sites and were more
ronounced in low shear as compared with high-shear
egions (flow divider); 2) in our autopsy series, there was a
reater prevalence of late stent thrombosis in bifurcation
esions treated with a DES as compared with a BMS; 3)
rterial healing was impaired with greater delay at the flow
ivider as compared with the lateral wall sites; and 4) in the
n vitro bifurcation model, flow disturbance increased after
tent placement at the flow divider site.
evelopment of atherosclerotic plaque in bifurcation
esion. It has been reported that the occurrence of
therosclerosis at bifurcations is closely related to local
DAL
Thr
Thr
C
F
H
n Lesion
axus stents in the ostium of the left anterior descending coronary artery (LAD)
ied suddenly 2 years after stent implantation. (Far left) Radiograph showed
(Thr) at the ostium of the LAD and LCX. (B, C) High-magnification images dem-
, E, G) Uncovered struts and adherent thrombus also were observed in all sec-
sence of thrombus and healed luminal surface with mild neointimal thickening.Thr
catio
ed 2 T
ient d
ombus
der. (D
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April 20, 2010:1679–87 Pathology of Bifurcation Lesion and Stentingemodynamic forces such as shear stress (1–3,14). More-
ver, some autopsy studies have demonstrated a higher
revalence of atherosclerotic plaques in the low-shear
egions in coronary bifurcation lesions (15,16). In the
resent study, we investigated the axial distribution of
oronary plaques in bifurcation lesions using a longitu-
inal sectioning method. The lateral wall (i.e., low-shear
reas) showed significantly greater prevalence of coronary
laque formation as compared with the flow divider sites
i.e., high-shear areas), which was consistent with the
ndings of previous studies (15,16). In addition to the
laque distribution, progressive atherosclerosis such as
ecrotic core formation was significantly more frequent
n the lateral wall (low-shear regions).
Plaque progression is initiated by endothelial dysfunction
ollowed by increased permeability of lipoproteins, upregu-
ation of adhesion molecules such as intercellular adhesion
olecules and vascular cell adhesion molecules, and leuko-
yte transmigration (4). It is well known that there is a
trong correlation between endothelial dysfunction and
ow-shear stress and oscillatory flow, which usually is
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Figure 5 Stent-Induced Flow Disturbances Within a Compliant
(A) Gross image of the in vitro stented bifurcation model. The (B) recorded pressu
logic conditions. (D) Boundary layer separation in the nonstented model was obse
line represents boundary layer). (E) After stenting, the boundary layer was increas
the boundary layer was decreased. (G) No flow disturbances were observed during
stented model, vortical structures (arrows) were present in the carinal region.bserved in the bifurcation lesions or in areas of abrupt
urvatures. Cheng et al. (17) reported that upregulation of
ndothelial nitric oxide synthase was observed in a high-
hear areas using a cast-induced increased shear stress model
n the mouse carotid artery. In a later study, Cheng et al.
18) showed elevated gene expressions of interleukin-6,
-reactive protein, intercellular adhesion molecules, vascu-
ar cell adhesion molecules, and vascular endothelial growth
actor in the low-shear area using the same model. Thus,
hear stress seems to play an important role not only in early
laque formation, but also its progression. In addition,
ifurcation angle variation also plays a central role, as shown
y Perktold et al. (19): the larger the angle of bifurcation,
he greater the turbulence. Moreover, the ratio of the caliber
rom the proximal to the distal or side branch also influences
he flow turbulence (20,21). Obtaining the 3-dimensional
tructure of the bifurcation along with postmortem angiog-
aphy results followed by digital reconstruction may be
seful to understand better the detail of atherosclerotic
laque development and its spatial distribution, which was
ot used in the present study.
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Pathology of Bifurcation Lesion and Stenting April 20, 2010:1679–87elayed arterial healing in the bifurcation lesion after
ES implantation. Polymer-based DESs have dramati-
ally reduced rates of restenosis and late lumen loss as
ompared with BMSs, according to randomized clinical
ivotal trials in de novo short noncomplex lesions (22,23).
ubsequently, this technology was used for a wider range of
esion morphologic features, such as bifurcation/ostial, left
ain coronary artery, and long lesions, which have been
eported to have a high incidence of restenosis and revas-
ularization rate (24–26). However, recent meta-analyses
eported higher rates of late stent thrombosis in DESs
27–29), especially for off-label indications (30). Although
e previously reported that bifurcation lesions are one of the
athologic risk factors for late stent thrombosis in both
MSs and DESs (10,31), the mechanism of late stent
hrombosis in a bifurcation lesion has not been explored
ully.
In the present study, although the difference remained of
orderline significance because of a limited sample size, a
reater incidence of late stent thrombosis was documented
n the DES group as compared with the BMS group at
ifurcation sites. Detailed morphometric and pathologic
nalysis revealed greater delayed arterial healing, as evi-
enced by incomplete stent coverage and fibrin deposition
n bifurcation lesions stented with a DES versus a BMS.
his difference was especially pronounced at the flow
ivider sites, where thrombi were observed to originate at
he site of uncovered struts. Furthermore, our in vitro
xperimental bifurcation model demonstrated that deploy-
ent of stents can alter boundary layer separation of the
ateral walls and can produce disturbances (vortical struc-
ures) at the carina. Regions of boundary layer separation are
ssociated with reduced levels of wall shear stress, poor mass
ransfer of blood flow and vessel wall, and an increase in
ime residence of circulating blood elements. Moreover, the
evelopment of vortical structures can prolong and alter
ocalized areas of low-flow regions and can influence drug
eposition, arterial healing post stenting, and local fibrin
nd platelet deposition (32–34).
Richter et al. (20) showed that a greater neointimal
ormation occurs in the lateral as compared with the flow
ivider walls after stent implantation in a porcine iliofem-
ral bifurcation model, which is consistent with our finding
n the present study. However, these differences were not
ignificant in the BMS group, which may be because of
ore rapid healing and more uniform neointimal formation
fter BMS implantation. Thus, a combination of drug effect
nd flow disturbance both are likely to accelerate the delayed
ealing in bifurcation lesion.
It has been reported that deploying multiple stents (both
n main vessels and side branches) to treat bifurcation lesion
ave higher restenosis and thrombosis rates as compared
ith a single stent with balloon angioplasty in the side
ranch (24). In the present study, we could not demonstrate
ignificant differences between single-stent and multistent
echniques in the incidence of clinical events, likely becausef the small number of samples. However, because delayed
rterial healing occurs in the presence of 1 stent, it seems
easonable that a multistent technique would produce, in
ven the best-case scenario, a similar result, as polymer and
rug levels are likely to be higher. Furthermore, based on
ur findings of plaque distribution (i.e., predominantly
istributed on the lateral wall), it may be possible to design
new stent that may cover only the lateral wall. This would
inimize the risk of stent thrombosis by reducing unnec-
ssary metals in the carinal region.
tudy limitations. Because the data are derived from
utopsy specimens, the results may not be representative of
ll patients who receive a DES and survive. Also, more
ggressive approaches have been applied recently in the
ES as compared with the BMS era, which may account
or some stent-related death. However, to the best of our
nowledge, this is the only autopsy study in which stented
ifurcation lesions were studied specifically to examine the
ascular responses to both a BMS and DES. It is not
ossible to conduct this type of analysis from clinical studies
ecause only pathologic analysis can provide high-resolution
mages to determine delayed healing in various regions of
he bifurcation sites. Therefore, we believe that the current
tudy provides valuable information that furthers our un-
erstanding of vascular responses to the DES.
onclusions
laque formation in native coronary bifurcations and neo-
ntimal growth after DES implantation showed substantial
ifferences between the flow divider and the lateral wall
egions. The greater prevalence of late stent thrombosis in
he DES group compared with the BMS group at autopsy
s likely related to an exaggerated delay of arterial healing,
hich may be caused primarily by flow disturbances in drug
etention.
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